- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | SARS-CoV-2 Variant-Coverage Fluorescent PCR Kit 200 copies/mL LOD |
| Catalog No. | MDKPK-0095 |
| Description | The Alta DiagnoTech SARS-CoV-2 nucleic acid detection kit uses fluorescent PCR with high-efficiency reverse transcriptase and Taq polymerase. An endogenous internal control monitors the workflow from sample collection through amplification, while UDG/dUTP chemistry helps prevent carryover contamination. |
| Intended Use | Detection of SARS-CoV-2 nucleic acid. |
| Principle / Technology | Fluorescent PCR using reverse transcriptase and Taq polymerase, with endogenous process control and UDG/dUTP carryover prevention. |
| Detection Method | Fluorescent PCR |
| Performance Range / Specifications | Stated detection limit is 200 copies/mL; the high-efficiency reverse transcriptase and Taq polymerase system is described as shortening amplification time; the page reports stable detection of Alpha, Beta, Delta and Omicron variants. |
| Sensitivity / LOD | 200 copies/mL |
| Components / Formulation | High-efficiency reverse transcriptase, Taq polymerase, endogenous internal control, UDG enzyme and dUTP contamination-control components. |
| Package Specifications | Single-tube, single-test reagent format available; no reaction-mixture preparation required |
| Quality Control | Endogenous internal control monitors the workflow from sample collection through amplification. |
| Key Features | 200 copies/mL detection limit Alpha, Beta, Delta and Omicron coverage Endogenous full-process control UDG/dUTP carryover prevention |
| Regulatory / Compliance | Verified for stable detection of Alpha, Beta, Delta and Omicron variants. |
| Product Type | Respiratory viral nucleic acid detection kit |
| Analytes / Targets | SARS-CoV-2 nucleic acid, including Alpha, Beta, Delta and Omicron variants |
| Genotypes / Variants Detected | SARS-CoV-2 Alpha, Beta, Delta and Omicron variants |
| Clinical Agreement | Reported positive agreement was 99.66%, negative agreement was 99.58% and overall agreement was 99.61%. |
For research use only, not for clinical use.
|
There is no product in your cart. |
Copyright © 2026 Alta DiagnoTech. All rights reserved.
